CELERA EXPANDS GENOMIC PROGRAM.(contract with Serono)

Celera Genomics (NYSE:CRA), an Applera Corporation business, has announced that Serono S.A. (SWX Swiss Exchange: SEO and NYSE: SRA), has signed a multi-year subscription agreement to Celera's proprietary genomic databases. Financial terms of the agreement were not disclosed.

"This agreement with Serono is important validation of Celera's genomic databases," said J. Craig Venter, Ph.D., Celera's president and chief scientific officer. "We believe that access to Celera's data can provide Serono, a leading-edge global biotechnology company, with accurate genomic informatio